Combatting the Effects of Stress & Intense Physical Activity: How Peptides Can Help Keep Your Body in Peak Condition

0 reactions
0 comments
Video Thumbnail

FREE

Play Button
We would love to hear your thoughts.
Join the discussion below
Summary

What Dr. Jean-Francois Tremblay will teach you about peptides

  • A brief history of peptide research
  • How certain types of peptides work as bioregulators and can help regulate the immune system.
  • How to utilize peptides to create a healthier body and mind 
  • The different categories of anti-aging peptides.

 

The Benefits to your Health

  • Combat the negative effects of aging and stress from intense physical activity.
  • Improve the function of specific organs to create their own regulating peptides.
  • The brain, kidneys, immune system, etc., all create their own peptides to increase or decrease function as needed.

 

Introduction to Dr. Jean-Francois Tremblay

Jean-Francois Tremblay is a Canadian biochemist and anti-aging specialist. In this Dr. Talk, Dr. Jean-Francois Tremblay discusses the anti-aging benefits of peptides. He also delves into the different categories of peptides and how each one affects different body parts. Dr. Tremblay specializes in anti-aging sports performance and general health. 

Anyone interested in physical fitness and performance health would not want to miss this exciting discussion!

A Practical Step to Starting Peptides 

Dr. Tremblay recommends patients try to pinpoint one or two weaknesses that they are genetically predisposed to, as determined by their genetic history and testing. From there, he suggests people then begin taking organ-specific peptides as a form of prevention. For example, if there is a history of lung weakness, it is beneficial to take a peptide focused on lung function. 

In one study, researchers gave a cartilage peptide and a generic joint supplement to patients suffering from joint pain. They discovered that the people who received both the peptides and the supplement saw the greatest improvement when it came to pain and stiffness.

Peptides, which are small amino acid chains that make up proteins, can help promote proper function in dozens of bodily systems.

Do note that some peptides don’t absorb well when taken orally, sublingually, or through a nasal spray. Sometimes an injection is the best method. Discuss your options with a healthcare professional. 

Conclusion

In this anti-aging Dr. Summit, Dr. Jean-Francois Tremblay discusses the benefits to different categories of peptides and how they can help with various illnesses, as well as aging. He also discusses preventive dosages of peptides. Dr. Tremblay has been interested in peptides for nearly 20 years and continues to spread awareness about the benefits that peptides hold. 

Improve your health using peptides by watching Dr. Tremblay’s Dr. Talk.

 

Exercise, Fitness, Peptides, Stress
Transcript
Kent Holtorf, M.D.

Yeah. Hi, this is Dr. Kent Holtorf for another episode of the peptide summit today, we’ll be interviewing, um, John Francoise Tremblay. I’m sure I butchered that, but, uh, he’s in talk about peptide bio regulators and upcoming therapy. Uh he’s. It is undergraduate studies and biochemistry, and also mechanical engineering and kinesiology. He then pursued his graduate studies in farms, uh, in pharmacy to finally complete his masters in pharmacology. Uh, his interest in peptides and their application started over 20 years ago. Uh, he is consulted privately since then. Anti-aging sports performance and general health. Uh, five years ago, he started his zone company, specializing the synthesis of peptides. Uh, you, he is the wonderful character and makes everyone smile. So I welcome you. Uh, uh, thank you for being on.

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Hey. No. Hey, thanks to you for having me.

 

Kent Holtorf, M.D.

Yeah. So, uh, we’ll talk a little about bio regulators. What, what the heck are regulars?

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Well, basically the first ever peptides that were discovered, uh, and that a lot of people like [inaudible] is one of them. So to start off with the word discovered, I couldn’t find any studies that are older than 30 years, but it’s that Russian doctor, uh, actually like almost 50 years ago. And they came out of at the time, the cold war and all that. So all of those view as they did at the, uh, government asked them to find something, to make their soldiers better. So is, uh, is, is admitted. Uh, he was a military and a military doctor, so he started to search and he came about, uh, peptides, uh, the first one being at Pisano then Timberland, and then he realized there is a bunch of them. So that’s basically, I started by Daron now. I’m not sure if the Russian were very happy,

 

Kent Holtorf, M.D.

Uh, we’ll call it a battalion and find me land just so,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Oh, Oh, we could talk about that. There is a huge difference between the Mulian and, uh, let us confusion on that, but then I’ll come back to that. Uh, so that’s how they started. And they found, he found that they had the profound effect again with the [inaudible] being the first one, the first with mice, then with, uh, dogs and monkeys and then humans. And he found a anti aging effect, but, and it’s mostly no for the telomere thing, you know, like LinkedIn, the telomere, but that actual part, and it was done like 12, 15 years ago. And I’m not sure they had the right ways or the accurate ways to measure telomeres. And I wouldn’t count on that actually at this point, but it has proven so many good effects that you cannot discard it, even if it doesn’t, if it were then doing nothing for its telomeres, uh, basically so, well, first that’s how it started. 

Then again, you discover, and right now there is a list of about it discovered more than 25, but there is a list of 25 that we know what they do. And we know they have the positive effects because it did discover more but found that they had no physiological effects. Maybe they were byproducts of a bigger peptides. We don’t know. So right now, and I know that he released a couple of years ago that he found like 50 over 50 more, but now he was in the face of finding which one do something. And so, and then he could start research on those ones. And when you say they found these, so where are they looking for these basically they’re glandular or Oregon extracts. And that that’s one of the beauty of it. 

They all very small peptides, two, three or four amino acids. Uh, and, and the funny way, not only the bio regulators, the smaller peptides are the one who has the bigger impacts on the body. I’m thinking about G H K uh, by the way, Kevin’s son, when he wrote about GFK, then discover it. But he said, well, I wish I had discovered that’s when you noticed that, uh, you have the TRH the Tyro Tropin releasing hormone three amino acids, but, and despite the name is, has a very small effect on the terror, but a player does a lot of things, things that are not true. So, you know, it’s those smaller ones, but those one, yeah. So they’re, they’re extract from organs or system and actually a pita. Now, knowing again, that’s empty. Aging is actual actually the bio regulator of the hormonal system. 

Uh, so you have to Madeline, that is the, the, the bio regulator of the immune system. And then violin is too. And the spleen by the same token, then there is one for the liver, one for the kidneys, one for the lungs, there are two or three for the brain and nervous system. So, you know, and basically each organ produce its own peptide that regulates that same Oregon, uh, to, uh, and the, the work a bit like, uh, adaptogens, you know, if a system is out of whack, it’s going to bring it down. If it’s not working well enough, it’s going to bring it up. So that’s another nice

 

Kent Holtorf, M.D.

What like a call, you know, BPC one 57 artificial compound that if they’re a hypercoaguable, it brings it down. If they don’t quite relate it enough, it brings it up. If their sugar is high, brings down our blood pressure.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah. Well it generally speaking, that’s the beauty of peptides that there are some, you know, they’re intelligent and their actions, not the intelligence. You cannot play chess with them, but in their actions. And that brings about fears from some people, because there are peptides, I divert the bed, but I think it’s important. Like BPC one, five, seven, or time is in beta for that are good to be used in, like, for example, in cancer cases. But a lot of people will jump because they say, Oh, but what about the angiogenesis? Well, that’s the beauty of it. The, they don’t push their actions. The peptide there will be on jewel Genesis if needed. So if in the case of cancerous cells around it and the angiogenesis is not needed, then it won’t happen. It will work for what it’s neither within the realm of what it can do as a peptide.

 

Kent Holtorf, M.D.

Again, this is, I mean, so does vitamin D you know?

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah, yeah. And, and not lately they have thought, well, maybe it’s there to help actually, you know?

 

Kent Holtorf, M.D.

Yeah. More climates of beta for around the cancer. So they say, Oh, it must be caused the cancer. Well, it’s like to be a buyer. I see these firemen. So these guys must be starting the fire.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah, exactly. There you go. That’s, that’s a concept that was wrongly interpreted before and now people are catching up to it. So basically they are very intelligent in what they do. So that’s why it’s rare to I’ve, uh, to have side effects from peptides. I’m not saying you cannot have effects, like are, do immune response, for example, but that’s not a side effect of the peptide. That’s a side effect from your condition. And not like people that are allergic to peanuts, uh, that the G is not a side effect of the peanut. It’s your condition that bring about immune dysfunction. That, yeah, exactly. So I haven’t found actual side effects from peptides. They always brought about by the condition where sometimes you have to be careful, but, uh, as, as, as doctors, it’s the kind of compounds you can use and you don’t have to worry that your, a client or patients will call you for the morning for an emergency

 

Kent Holtorf, M.D.

Doctors. I say, you know, you can’t really screw it up. So don’t yeah.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

And, and more so of BPC when five, seven, uh, the, before I call them Mara improve that, meaning that if somebody comes to you and you don’t know what’s wrong, given those two and something good will happen. So the, um, uh, uh, an epitaph alien, or however you pronounce it. Yeah. You know, like, you know, the studies showing like menopausal rats, you know, they start menstruating again and actually bad babies. Um, and we’ve used them for fertility and we haven’t really seen someone start menstruating again, but they’re, um, uh, they’re um, uh, FSH and LH will come down and their, um, uh, AMH wall, which tells us a very reserved lecture go up. So it does seem to anti-age the, uh, the antebellum.

 

Kent Holtorf, M.D.

Yeah. And so, yeah, it’s interesting in that sense, I’ve used it a lot, many years ago when I was still training people with, uh, with woman, uh, wherever, like in the physique competition, or are any kind of very demanding competitions where they have a very strict diet. Sometimes they would take things that would with their hormonal system off substances and all that. And, uh, and the actual stress of training. So right after the competition, I would put them right up on the pizza lawn and tree three, four, five days, everything was coming back to normal and they would sleep like crazy 12, 13 hours. But, you know, it was a system pushing them to go home and like put them back on track very, very fast or morally. And, um,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

The battalion versus pinene, Leon different effects.

 

Kent Holtorf, M.D.

Yeah, of course, Biennale alone is a brain that diets, uh, and it does have an effect on the nervous system. So, uh, we started to use it, not me, I’m not a doctor, but a few practitioners I keep up with, uh, you know, feed them, uh, on the actually serious cases of, uh, neurodegenerative diseases, uh, alone. Now it’s from the actual brain. I don’t know why they call it the nail alone. I don’t think it’s from the pineal gun or might be, I’m not sure about this one, but the effect is in the cortex of the brain and the nervous system. So in any case of neurodegenerative, uh, uh, conditions, they, they have a good effect, but, uh, in therapeutic dosages, not in preventive dosages. 

So, uh, basically meaning again for repeat along the classic, those ages, like a total of a hundred milligrams twice a year. And I would come back white only twice a year, but, but keep in mind, that’s, you know, that’s, uh, anti aging protocol and it’s basically a preventive, you prevent aging and, uh, age, age related diseases. Uh, so, and you see the full effect. When you look at the studies by Kevin sun, it’s over 12, 15 years where you see all those results. Uh, so people, many times they start using them and it’s on you. I didn’t feel anything well, okay. Well, if you start smoking today, it’s gonna take maybe 10, 20, 30 years before they cancer show up. It is happening.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah. Like my mom said, I have to smoke five packs a day. She goes, Oh, so and so got, never got cancer, you know, but, um, uh, yeah. And the study where they gave the epitaph alien with, uh,, uh, uh, on cardiovascular patients, significant cardiovascular disease, um, over 65, I believe a hundred and something patients bought them for 15 years and the ones on the treatment, uh, basically their heart function got better, dramatically, less cancer, dramatically, less cardiovascular disease, uh, lived longer, less morbidity, the better quality of life. Pretty amazing.

 

Kent Holtorf, M.D.

Basically everything that normally goes down, goes back up and, uh, uh, survival rate increased by 67%. Now, there are amazing, uh, about Tim Allen and Tim Mulan. There actually are very two different peptides. The Malin, when a it’s two amino acid peptide, and that’s the bio regulator, the Mulan is a product of the immune system, the same as diamonds and alpha one. So to understand the concept, uh, the Mulan would be true. The timers where insulin is to the pancreas. So if you have a diabetes, you take insulin, it will regulate your sugar levels, but it won’t do nothing for the, uh, pancreas. So the T Mulan will regulate your immune system. That’s why it’s very good peptide, but it won’t do anything to regulate your timeless as the Malian with the neck will. So when it’s available here, well, the problem Timberland actually, uh, most of the time, you’ll see the Mulan sold as demolition. Uh, the end result is good and that’s what you want upregulation of the immune system. But, uh, the point we made some [inaudible] and we found out that it’s two amino acids, doesn’t dissolve in water. So if you buy something that’s re it’s a stimulant and you can dissolve it

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Water site. Well, maybe that would a Zuora orally than, uh, cause that’s the big problem with that.

 

Kent Holtorf, M.D.

Probably sublingual. Yeah. In that case, usually if they’re more, uh, uh, uh, like I draw a fob, then they can be absorbed the sub.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah. That’s the big problem is they’re very polar and hides. It’s so hard to get them to absorb. And a lot of people are just putting them in nasal sprays and just assuming or sublingual, assuming they’re going to absorb, but you can’t. And, and again, you know, they’re not that expensive, but they’re not cheap. You know, why, you know, just injected that’s where you get the most bang for your buck. You get to a hundred percent of it and then, then no diabetics, they do it like many times a day. And they’re fine with that. Usually women are fine. Men suppositories would be good, but then again, that’s sure both better with it to be happy about that.

 

Kent Holtorf, M.D.

Gotcha. Gotcha. What, what other, um, bio regulator have you found effective? What,

 

Kent Holtorf, M.D.

Yeah. Hi, this is Dr. Kent Holtorf for another episode of the peptide summit today, we’ll be interviewing, um, John Francoise Tremblay. I’m sure I butchered that, but, uh, he’s in talk about peptide bio regulators and upcoming therapy. Uh he’s. It is undergraduate studies and biochemistry, and also mechanical engineering and kinesiology. He then pursued his graduate studies in farms, uh, in pharmacy to finally complete his masters in pharmacology. Uh, his interest in peptides and their application started over 20 years ago. Uh, he is consulted privately since then. Anti-aging sports performance and general health. Uh, five years ago, he started his zone company, specializing the synthesis of peptides. Uh, you, he is the wonderful character and makes everyone smile. So I welcome you. Uh, uh, thank you for being on.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Hey. No. Hey, thanks to you for having me.

 

Kent Holtorf, M.D.

Yeah. So, uh, we’ll talk a little about bio regulators. What, what the heck are regulars?

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Well, basically the first ever peptides that were discovered, uh, and that a lot of people like [inaudible] is one of them. So to start off with the word discovered, I couldn’t find any studies that are older than 30 years, but it’s that Russian doctor, uh, actually like almost 50 years ago. And they came out of at the time, the cold war and all that. So all of those view as they did at the, uh, government asked them to find something, to make their soldiers better. So is, uh, is, is admitted. Uh, he was a military and a military doctor, so he started to search and he came about, uh, peptides, uh, the first one being at Pisano then Timberland, and then he realized there is a bunch of them. So that’s basically, I started by Daron now. I’m not sure if the Russian were very happy,

 

Kent Holtorf, M.D.

Uh, we’ll call it a battalion and find me land just so,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Oh, Oh, we could talk about that. There is a huge difference between the Mulian and, uh, let us confusion on that, but then I’ll come back to that. Uh, so that’s how they started. And they found, he found that they had the profound effect again with the [inaudible] being the first one, the first with mice, then with, uh, dogs and monkeys and then humans. And he found a anti aging effect, but, and it’s mostly no for the telomere thing, you know, like LinkedIn, the telomere, but that actual part, and it was done like 12, 15 years ago. And I’m not sure they had the right ways or the accurate ways to measure telomeres. And I wouldn’t count on that actually at this point, but it has proven so many good effects that you cannot discard it, even if it doesn’t, if it were then doing nothing for its telomeres, uh, basically so, well, first that’s how it started. 

Then again, you discover, and right now there is a list of about it discovered more than 25, but there is a list of 25 that we know what they do. And we know they have the positive effects because it did discover more but found that they had no physiological effects. Maybe they were byproducts of a bigger peptides. We don’t know. So right now, and I know that he released a couple of years ago that he found like 50 over 50 more, but now he was in the face of finding which one do something. And so, and then he could start research on those ones. And when you say they found these, so where are they looking for these basically they’re glandular or Oregon extracts. And that that’s one of the beauty of it. 

They all very small peptides, two, three or four amino acids. Uh, and, and the funny way, not only the bio regulators, the smaller peptides are the one who has the bigger impacts on the body. I’m thinking about G H K uh, by the way, Kevin’s son, when he wrote about GFK, then discover it. But he said, well, I wish I had discovered that’s when you noticed that, uh, you have the TRH the Tyro Tropin releasing hormone three amino acids, but, and despite the name is, has a very small effect on the terror, but a player does a lot of things, things that are not true. So, you know, it’s those smaller ones, but those one, yeah. So they’re, they’re extract from organs or system and actually a pita. Now, knowing again, that’s empty. Aging is actual actually the bio regulator of the hormonal system. Uh, so you have to Madeline, that is the, the, the bio regulator of the immune system. And then violin is too. And the spleen by the same token, then there is one for the liver, one for the kidneys, one for the lungs, there are two or three for the brain and nervous system. So, you know, and basically each organ produce its own peptide that regulates that same Oregon, uh, to, uh, and the, the work a bit like, uh, adaptogens, you know, if a system is out of whack, it’s going to bring it down. If it’s not working well enough, it’s going to bring it up. So that’s another nice

 

Kent Holtorf, M.D.

What like a call, you know, BPC one 57 artificial compound that if they’re a hypercoaguable, it brings it down. If they don’t quite relate it enough, it brings it up. If their sugar is high, brings down our blood pressure.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah. Well it generally speaking, that’s the beauty of peptides that there are some, you know, they’re intelligent and their actions, not the intelligence. You cannot play chess with them, but in their actions. And that brings about fears from some people, because there are peptides, I divert the bed, but I think it’s important. Like BPC one, five, seven, or time is in beta for that are good to be used in, like, for example, in cancer cases. But a lot of people will jump because they say, Oh, but what about the angiogenesis? Well, that’s the beauty of it. The, they don’t push their actions. The peptide there will be on jewel Genesis if needed. So if in the case of cancerous cells around it and the angiogenesis is not needed, then it won’t happen. It will work for what it’s neither within the realm of what it can do as a peptide.

 

Kent Holtorf, M.D.

Again, this is, I mean, so does vitamin D you know?

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah, yeah. And, and not lately they have thought, well, maybe it’s there to help actually, you know?

 

Kent Holtorf, M.D.

Yeah. More climates of beta for around the cancer. So they say, Oh, it must be caused the cancer. Well, it’s like to be a buyer. I see these firemen. So these guys must be starting the fire.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah, exactly. There you go. That’s, that’s a concept that was wrongly interpreted before and now people are catching up to it. So basically they are very intelligent in what they do. So that’s why it’s rare to I’ve, uh, to have side effects from peptides. I’m not saying you cannot have effects, like are, do immune response, for example, but that’s not a side effect of the peptide. That’s a side effect from your condition. And not like people that are allergic to peanuts, uh, that the G is not a side effect of the peanut. It’s your condition that bring about immune dysfunction. That, yeah, exactly. So I haven’t found actual side effects from peptides. They always brought about by the condition where sometimes you have to be careful, but, uh, as, as, as doctors, it’s the kind of compounds you can use and you don’t have to worry that your, a client or patients will call you for the morning for an emergency

 

Kent Holtorf, M.D.

Doctors. I say, you know, you can’t really screw it up. So don’t yeah.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

And, and more so of BPC when five, seven, uh, the, before I call them Mara improve that, meaning that if somebody comes to you and you don’t know what’s wrong, given those two and something good will happen. So the, um, uh, uh, an epitaph alien, or however you pronounce it. Yeah. You know, like, you know, the studies showing like menopausal rats, you know, they start menstruating again and actually bad babies. Um, and we’ve used them for fertility and we haven’t really seen someone start menstruating again, but they’re, um, uh, they’re um, uh, FSH and LH will come down and their, um, uh, AMH wall, which tells us a very reserved lecture go up. So it does seem to anti-age the, uh, the antebellum.

 

Kent Holtorf, M.D.

Yeah. And so, yeah, it’s interesting in that sense, I’ve used it a lot, many years ago when I was still training people with, uh, with woman, uh, wherever, like in the physique competition, or are any kind of very demanding competitions where they have a very strict diet. Sometimes they would take things that would with their hormonal system off substances and all that. And, uh, and the actual stress of training. So right after the competition, I would put them right up on the pizza lawn and tree three, four, five days, everything was coming back to normal and they would sleep like crazy 12, 13 hours. But, you know, it was a system pushing them to go home and like put them back on track very, very fast or morally. And, um,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

The battalion versus pinene, Leon different effects.

 

Kent Holtorf, M.D.

Yeah, of course, Biennale alone is a brain that diets, uh, and it does have an effect on the nervous system. So, uh, we started to use it, not me, I’m not a doctor, but a few practitioners I keep up with, uh, you know, feed them, uh, on the actually serious cases of, uh, neurodegenerative diseases, uh, alone. Now it’s from the actual brain. I don’t know why they call it the nail alone. I don’t think it’s from the pineal gun or might be, I’m not sure about this one, but the effect is in the cortex of the brain and the nervous system. So in any case of neurodegenerative, uh, uh, conditions, they, they have a good effect, but, uh, in therapeutic dosages, not in preventive dosages. So, uh, basically meaning again for repeat along the classic, those ages, like a total of a hundred milligrams twice a year. And I would come back white only twice a year, but, but keep in mind, that’s, you know, that’s, uh, anti aging protocol and it’s basically a preventive, you prevent aging and, uh, age, age related diseases. Uh, so, and you see the full effect. When you look at the studies by Kevin sun, it’s over 12, 15 years where you see all those results. Uh, so people, many times they start using them and it’s on you. I didn’t feel anything well, okay. Well, if you start smoking today, it’s gonna take maybe 10, 20, 30 years before they cancer show up. It is happening.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah. Like my mom said, I have to smoke five packs a day. She goes, Oh, so and so got, never got cancer, you know, but, um, uh, yeah. And the study where they gave the epitaph alien with, uh,, uh, uh, on cardiovascular patients, significant cardiovascular disease, um, over 65, I believe a hundred and something patients bought them for 15 years and the ones on the treatment, uh, basically their heart function got better, dramatically, less cancer, dramatically, less cardiovascular disease, uh, lived longer, less morbidity, the better quality of life. Pretty amazing.

 

Kent Holtorf, M.D.

Basically everything that normally goes down, goes back up and, uh, uh, survival rate increased by 67%. Now, there are amazing, uh, about Tim Allen and Tim Mulan. There actually are very two different peptides. The Malin, when a it’s two amino acid peptide, and that’s the bio regulator, the Mulan is a product of the immune system, the same as diamonds and alpha one. So to understand the concept, uh, the Mulan would be true. The timers where insulin is to the pancreas. So if you have a diabetes, you take insulin, it will regulate your sugar levels, but it won’t do nothing for the, uh, pancreas. So the T Mulan will regulate your immune system. That’s why it’s very good peptide, but it won’t do anything to regulate your timeless as the Malian with the neck will. So when it’s available here, well, the problem Timberland actually, uh, most of the time, you’ll see the Mulan sold as demolition. Uh, the end result is good and that’s what you want upregulation of the immune system. But, uh, the point we made some [inaudible] and we found out that it’s two amino acids, doesn’t dissolve in water. So if you buy something that’s re it’s a stimulant and you can dissolve it

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Water site. Well, maybe that would a Zuora orally than, uh, cause that’s the big problem with that.

 

Kent Holtorf, M.D.

Probably sublingual. Yeah. In that case, usually if they’re more, uh, uh, uh, like I draw a fob, then they can be absorbed the sub.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah. That’s the big problem is they’re very polar and hides. It’s so hard to get them to absorb. And a lot of people are just putting them in nasal sprays and just assuming or sublingual, assuming they’re going to absorb, but you can’t.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

And, and again, you know, they’re not that expensive, but they’re not cheap. You know, why, you know, just injected that’s where you get the most bang for your buck. You get to a hundred percent of it and then, then no diabetics, they do it like many times a day. And they’re fine with that. Usually women are fine. Men suppositories would be good, but then again, that’s sure both better with it to be happy about that.

 

Kent Holtorf, M.D.

Gotcha. Gotcha. What, what other, um, bio regulator have you found effective? What,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Um, personally I’ve particularly okay. Peter Long, Tim, Tim Mullin and Tim Mulan, uh, in cases of, uh, cancer. And of course in anti aging, uh, protocols, uh, P&L alone. We’re using a lot now, uh, Carta, lax, which is the joint. And, um, it’s a gradation, uh, peptide, uh, is, is good. I wouldn’t say amazing. They good, but there is that one Russian study done by Kevin sun where they at four groups, they gave one group a, the Carta lacks, the second group, they gave, um, cartilage, a supplement that you buy at the pharmacy. Uh, because to me that meant, so they gave like the class say 1500 milligrams, then the third group where they gave boats and a forum where they give nothing. So they found that Carta, lax and glucosamine, which is actually a good supplement. I pretty much the same effect on joints pain. And they measure the things, but they found that when you use them together, then you have a synergetic effect and bang, you get a bigger effect and, uh, on the joints. 

So that one, if she wants the most other vet, you take it with a different mechanisms and should go ahead and have you found, um, uh, I am, some of that was trying for blood vessels. I haven’t a lot of experience with it yet. We make it, but not on paper. It looks great, but I cannot talk out of experience on this one yet. Yeah. So we tried that in the one for the kidneys. Uh, yeah. So don’t know yet, but it’s been a blood work. Usually what I’ve found in general, the difference between preventive dose age and therapeutic is there is a ratio, a ratio of about one to five, one to 10. So like a bit alone. We saw good results in cancer, like almost overnight, but they were taking 30 milligrams a day and nonstop. 

They wouldn’t stop after 10 days. Same thing. You know, if it’s therapeutically again, just like bump them up as much as it gets a little pricey. That’s a thing I’ve heard. You mentioned like the time was in beta for a study on how high they went and yeah. Uh, it’s one study that was done in 2010 with time as in beta four, they went up 2000, 260 milligrams. So like, let’s say you work with the milligram vials. That’s 126 vials. So of course IVs and after, and then you man. So they, after two weeks, basically they concluded that it was armless with a few minor side effects in some cases, but overall, and obviously they concluded, we won’t try higher because nobody will ever use that much.

 

Kent Holtorf, M.D.

Cause we’re using microgram doses. That’s a thousand times.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

No,

 

Kent Holtorf, M.D.

Try that with anything out there trying to with Tylenol, try it with water.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

No, you cannot. No. So basically I except for a few like L 37, which is a antiviral and the, I, it may have serious side effects. If you think too much like a few, a few, you have to be careful.

 

Kent Holtorf, M.D.

We started very well. Cause I was looking and I blind myself, but started elders. I could not find any dosing, uh, except for a rat though, say, am I okay? I’ll try this. I did. Oh my gosh. Way to so much, it just killed the oven. So I had the biggest hurt, angry come out of my skin. So, uh, and ends up, we give a fry or a tiny fraction that dose, but I, I do like that peptide, but yeah, that’s one. You gotta be fair be

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

No, no, no. But a general. Yeah, no, I don’t see a again, as I expressed before, it’s basically, okay. Let’s say you have a auto immune condition. You may have a reaction, not to immune response to the actual peptide. So even though you have to be careful with those, but those are not side effects from the peptide. There are side effects are in effect from the condition.

 

Kent Holtorf, M.D.

Well, and that’s yeah, it’s interesting. And I really found this out in myself. It will get people say, you know, they get a big, well, when they do the injection and say, okay, it’s allergic, you know, but I found them myself when I was sick and my immune system was off. I would get the biggest welts. And then as I got better, I would inject and not would never not get the well, you know, so really see people get kind of that wealth from it. It shows they have immune dysfunctions. Exactly. I don’t think it’s a standard allergic reaction.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

No, no, no. And, and many times if it’s serious as a reaction, because I’ve seen a couple of times actually people have a very bad reaction, but yeah, at that point you introduced him as an alpha one for a few days or a week. And then you can start the actual bedside therapy. If time is an alpha one, wasn’t there. And usually you can balance then they don’t, they don’t have that. So like when I give talks on paper

 

Kent Holtorf, M.D.

Tides and go through all these studies that the typically sponsored doctors are, why haven’t I heard of these?

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

No, I get it. I get that. I get that a lot. What’s your thought on that? Well, big pharmaceutical companies, they knew above that all the time. You just shut up about it. I’m not, not there. They’re in the game of peptides. Uh, they found a way true, probably a very expensive lobbying because peptides, you cannot pattern them per se. Cause you know, they’re produced. But now they went around that. And if you look at the latest patents of peptides, they pattern the way you make it, which is easy to go around. But they pattern the application of, so it’s in the title, a pattern for this peptide and its application. And then they will list everything they know it’s good for. 

So what’s the implication is since it’s patented, now they put it on the market. So you as a doctor, let’s say you prescribe a time. As in beta four, then you were it out to your client, to the pharmacy or a compounding pharmacy. I’m not sure if that will be required by you to write why you prescribe it, prescribe it. But most likely the pharmacist will ask, what is it for? Or maybe it’s going to call you. So if it falls within one of those conditions, then by law, it will be forced to sell to the patient. The one that is made by that pharmaceutical company.

 

Kent Holtorf, M.D.

What I don’t understand, I’ve seen these two. It’s like they’re yeah. Uh, they’re taking peptides of all this research and then, and then getting a patent on the application when I thought that would not be allowed because if a person in the industry, it would not be obvious that then they can patent it, but there’s studies on it showing it does this and that. And then they get a patent on it for that. So it seems like I’m like, how can that be? You know?

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Well, that’s, that’s the sickness of our, uh, pharmaceutical system basically. It’s yeah. It’s like, shouldn’t be, but uh,

 

Kent Holtorf, M.D.

40 years. And then they patented under four conditions.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

There you go. That’s and that’s what they’re aiming at now. And that’s why they got into the game. And that’s why you see things happening slowly. But you know, like with TaylorMade they say, okay, you cannot make this one, this one or this one anymore. And they’re slowly getting to that.

 

Kent Holtorf, M.D.

Don’t worry about compounding pharmacies. And they have the thing with the, we could only where they had a list that you couldn’t compound. Now they’re going to list that this Alicia can compound from, there’s going to be very few things. Like they said things like, Oh, you can’t compound course a 10 because we have a drug for that.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah. So the same argument,

 

Kent Holtorf, M.D.

You know, and, or they’ll say it’s difficult to compound, well difficult for whom.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Right? Let, let, let me leave it to us if it’s difficult or that

 

Kent Holtorf, M.D.

Yeah. And I think com there’s going to be very few things and are, they’ll say, well, someone cakes too much, they could have a problem. You know? And, and with these doctors that were debating, this should be allowed, uh, they would say, well, they wouldn’t even look at the literature. They don’t need to look the literature. Um, yeah, like I’ll fight folic acid. They said, can’t be given IB. Um, and they just eliminating everything. They said they weren’t going to text the hormones, but that’s gonna be on the list. I’m very worried that T3 is going to be gone because they’re going to say, Oh, it’s not necessary. We have Synthroid.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Well, that’s what they did in Canada. You cannot find Teatree anymore. For many years, two, four, that’s it centroid T four. And that’s the only thing there is still like in Montreal, there was one pharmacy compounding pharmacy where I get my, uh, uh, armor, uh, extract. And this is it. And most, uh, Andrew, uh, other chronologist, they, no, they say, no, you ask them, they’re going to say no too far is that.

 

Kent Holtorf, M.D.

Yeah. And you know, I written numerous reviews on how T4 doesn’t work for anyone, especially any sick person. Um, and with hundreds of references, you know, but it feels like, no, no, no, you don’t need it. And I’ll say, it’s dangerous. It’s like, are you kidding me?

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

And, and as a practitioner, you should know. And because I have a doctor, I actually got suspended for nine months because he prescribed the, uh, the, the extract and what he said. Yeah. On paper and studies. Yeah. They do pretty much the same thing. But he said, if you ask the patients are, do you feel, and 80% will tell you, they feel much better with the extract than with the synthetic T four. So yeah, the blood levels, they’re both good.

 

Kent Holtorf, M.D.

It’s like they had bipolar patients that were treatment resistant. They tried on average 14 medication with no improvement. They gave them straight T3, uh, and 80% improved. And, uh, 75% had total resolution of several, I’m sorry, 35% or something like that. Total resolution of symptoms. Yup. T board doesn’t work in these patients there don’t utilize it. But anyways

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

and, and most, probably some cofactors we don’t even know about yet that support.

 

Kent Holtorf, M.D.

So it sounds like very hopefully upcoming thing. And it doesn’t get quashed by, you know, big pharma and the medical board and FDA are all kind of boots. Um, so yeah. So with, uh, kind of in closing, I think this is really upcoming thing. Where, where do you think it’s kind of an lead?

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Well, I’m just going to say this. Why do you think so many of us and Canadian doctors open clinics in Mexico and the Caribbean? Uh, it’s not because yeah, of course it’s nice, big idea that I would love to have an office there, but that’s not their first reason it’s for that reason basically. So they can continue to offer the best treatments without being bothered by FDA regulations.

 

Kent Holtorf, M.D.

Yeah. And it’s even, I think, you know, in this whole integrative space or whatever you want to call it, you know, the standard doctor was, Oh, there’s no evidence, you know, uh, which is crazy. It’s more evidence-based than what you learn and you know,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

And, uh, it’s, it’s actually a sad thing. That’s happening in medicine in general, you know, 30 years ago when I was young, I would go see because as a doctor, what’s the first thing you do. First thing, when you see a patient, you ask him questions, no tests, no nothing. First questions. And if you’re good, just with that, you know, what’s wrong with him, but now the system, like it doesn’t trust you anymore. They force you to do all those tests to back up your diagnosis that you had probably with 10, 10, 15, depending, but very fast know, after if you have a doctor that has a bit of experience and say, yeah, this is it. This is this. Sometimes they will net a couple of tests. Maybe it’s lupus, maybe it’s fibromyalgia. Let’s look at it, but you have a pretty good idea. Now the system forces you to back up everything you do, why you do it and everything. And I find it amazingly sad because it’s like that all that formation, that knowledge and experience, and suddenly they’re telling you, no, we don’t trust you. Yeah.

 

Kent Holtorf, M.D.

And everything comes down now to terms of the protocols that especially hospital or anyone affiliated with Kaiser or whatever it may be. You do this, do this. Everything is memorization. And it’s, you know, the art of medicine has gone. And I think at some point it’s going to be put all their labs and symptoms in a computer. It’s gonna,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah. AI, that’s where it’s going to.

 

Kent Holtorf, M.D.

And that’s the thing. So all these patients that works well for patients fits in a little box, but if they don’t, that system breaks down and that’s we get the doctor goes, Oh, you must be in your head. You know, that’s a classic, basically they are in the limbo, which I think is where peptides that have a big place. And I think you’d agree with that.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

If things would go as they should, the future of medicine, and I’m talking five to 10 years, no more, because things are moving fast, you would go see a doctor and probably 60, 70% of this prescriptions would be that diets. And soon not now because with the, um, or, uh, biomes, you know, the, the, the probiotics we have, uh, not, not they’re mapping it, but it’s going to be like the, uh, DNA, you know, you map it. And, you know, 20 years ago said, that’s it though. We, we got it. Then it’d be genetic game. So I think there is a net beach and there’d be biome that goes with that interactions. But once they get down that path, that’s going to be a mainstream. It should be a mainstream in medicine. Right.

 

Kent Holtorf, M.D.

But it’s going to get more complicated because they’re finding the virome, you know, the bacteria, phages, the viruses of the bacteria play a big part. So there it’s very complex

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Tomorrow, but I have big hope cause things are happening faster and faster, another five, 10 years. And they should have a pretty good idea of what to do with that. And that’s going to be a big, big line in medicine to use. I think it’s good.

 

Kent Holtorf, M.D.

Right. So, so just kind of, uh, in closing here, you’d say, um, at battalions, probably the main bio regulator,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

It’s kind of our mono system, you know, that’s regulated the most experience with Andy and Tamerlan. Well, even if you use one that it’s called DEMA land that’s to Mulan. It’s good. It’s that basically, because in those, uh, uh, aging studies and it figures, it Pitano is good. You add [inaudible] or violin, which is, and you can inject it while they’re salute. Uh, if you have a strong immune system, you will get less sick. So hands healthy, more healthy, and yeah, Broley you live longer

 

Kent Holtorf, M.D.

Also, but the immune system goes along with monitoring the body for cancer cancer,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

The, the main ones and the anti aging protocol, Peter Long, and [inaudible] violent time as an alpha one. You know, one of those will do the trick, uh, that combination it’s a winning company.

 

Kent Holtorf, M.D.

Yeah. I think those are the most studied as well. Yeah. Yeah. And we liked that combination and the other

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Ones in term of prevention, like the one for the lever and the one for the kidneys for, I would use them in the preventative approach, like a bit alone, if you add a familiar background. So let’s say, you say like half of my family, uh, they got, uh, diabetes. Well, okay. Maybe that’s not so much genetic. It could be you as you pass to your children the way you eat. So it may not be that genetic after all, but anyway, if there is a condition that really then yeah. You could use preventively, the one for the pancreas, if in your family, there is a Whitney weakness for the lungs then. Yeah. Don’t, I, I wouldn’t suggest everybody to use them all, then you’d be taken so many. Yeah. But just to pinpoint one thing or two that you see as kind of a weakness in your family, that’s a good indication. And then you can throw in those and the preventive, uh, protocol. Gotcha.

 

Kent Holtorf, M.D.

Great. Yeah. We’ll see what the future holds and I hope we’ll be talking more about all these and, uh, my pleasure. Yeah. So I thank you so much again, uh, love your personality and, uh, and you’re always searching for new knowledge at this. Wonderful. And so I’d like to thank you for being on with us. Hey, you’re very welcome. My pleasure. Great. Alright, goodbye.

Um, personally I’ve particularly okay. Peter Long, Tim, Tim Mullin and Tim Mulan, uh, in cases of, uh, cancer. And of course in anti aging, uh, protocols, uh, P&L alone. We’re using a lot now, uh, Carta, lax, which is the joint. And, um, it’s a gradation, uh, peptide, uh, is, is good. I wouldn’t say amazing. They good, but there is that one Russian study done by Kevin sun where they at four groups, they gave one group a, the Carta lacks, the second group, they gave, um, cartilage, a supplement that you buy at the pharmacy. Uh, because to me that meant, so they gave like the class say 1500 milligrams, then the third group where they gave boats and a forum where they give nothing. 

So they found that Carta, lax and glucosamine, which is actually a good supplement. I pretty much the same effect on joints pain. And they measure the things, but they found that when you use them together, then you have a synergetic effect and bang, you get a bigger effect and, uh, on the joints. So that one, if she wants the most other vet, you take it with a different mechanisms and should go ahead and have you found, um, uh, I am, some of that was trying for blood vessels. I haven’t a lot of experience with it yet. We make it, but not on paper. It looks great, but I cannot talk out of experience on this one yet. Yeah. So we tried that in the one for the kidneys. Uh, yeah. 

So don’t know yet, but it’s been a blood work. Usually what I’ve found in general, the difference between preventive dose age and therapeutic is there is a ratio, a ratio of about one to five, one to 10. So like a bit alone. We saw good results in cancer, like almost overnight, but they were taking 30 milligrams a day and nonstop. They wouldn’t stop after 10 days. Same thing. You know, if it’s therapeutically again, just like bump them up as much as it gets a little pricey. That’s a thing I’ve heard. You mentioned like the time was in beta for a study on how high they went and yeah. Uh, it’s one study that was done in 2010 with time as in beta four, they went up 2000, 260 milligrams. So like, let’s say you work with the milligram vials. That’s 126 vials. So of course IVs and after, and then you man. So they, after two weeks, basically they concluded that it was armless with a few minor side effects in some cases, but overall, and obviously they concluded, we won’t try higher because nobody will ever use that much.

 

Kent Holtorf, M.D.

Cause we’re using microgram doses. That’s a thousand times.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

No,

 

Kent Holtorf, M.D.

Try that with anything out there trying to with Tylenol, try it with water.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

No, you cannot. No. So basically I except for a few like L 37, which is a antiviral and the, I, it may have serious side effects. If you think too much like a few, a few, you have to be careful.

 

Kent Holtorf, M.D.

We started very well. Cause I was looking and I blind myself, but started elders. I could not find any dosing, uh, except for a rat though, say, am I okay? I’ll try this. I did. Oh my gosh. Way to so much, it just killed the oven. So I had the biggest hurt, angry come out of my skin. So, uh, and ends up, we give a fry or a tiny fraction that dose, but I, I do like that peptide, but yeah, that’s one. You gotta be fair be

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

No, no, no. But a general. Yeah, no, I don’t see a again, as I expressed before, it’s basically, okay. Let’s say you have a auto immune condition. You may have a reaction, not to immune response to the actual peptide. So even though you have to be careful with those, but those are not side effects from the peptide. There are side effects are in effect from the condition.

 

Kent Holtorf, M.D.

Well, and that’s yeah, it’s interesting. And I really found this out in myself. It will get people say, you know, they get a big, well, when they do the injection and say, okay, it’s allergic, you know, but I found them myself when I was sick and my immune system was off. I would get the biggest welts. And then as I got better, I would inject and not would never not get the well, you know, so really see people get kind of that wealth from it. It shows they have immune dysfunctions. Exactly. I don’t think it’s a standard allergic reaction.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

No, no, no. And, and many times if it’s serious as a reaction, because I’ve seen a couple of times actually people have a very bad reaction, but yeah, at that point you introduced him as an alpha one for a few days or a week. And then you can start the actual bedside therapy. If time is an alpha one, wasn’t there. And usually you can balance then they don’t, they don’t have that. So like when I give talks on paper

 

Kent Holtorf, M.D.

Tides and go through all these studies that the typically sponsored doctors are, why haven’t I heard of these?

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

No, I get it. I get that. I get that a lot. What’s your thought on that? Well, big pharmaceutical companies, they knew above that all the time. You just shut up about it. I’m not, not there. They’re in the game of peptides. Uh, they found a way true, probably a very expensive lobbying because peptides, you cannot pattern them per se. Cause you know, they’re produced. But now they went around that. And if you look at the latest patents of peptides, they pattern the way you make it, which is easy to go around. But they pattern the application of, so it’s in the title, a pattern for this peptide and its application. And then they will list everything they know it’s good for. So what’s the implication is since it’s patented, now they put it on the market. So you as a doctor, let’s say you prescribe a time. As in beta four, then you were it out to your client, to the pharmacy or a compounding pharmacy. I’m not sure if that will be required by you to write why you prescribe it, prescribe it. But most likely the pharmacist will ask, what is it for? Or maybe it’s going to call you. So if it falls within one of those conditions, then by law, it will be forced to sell to the patient. The one that is made by that pharmaceutical company.

 

Kent Holtorf, M.D.

What I don’t understand, I’ve seen these two. It’s like they’re yeah. Uh, they’re taking peptides of all this research and then, and then getting a patent on the application when I thought that would not be allowed because if a person in the industry, it would not be obvious that then they can patent it, but there’s studies on it showing it does this and that. And then they get a patent on it for that. So it seems like I’m like, how can that be? You know?

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Well, that’s, that’s the sickness of our, uh, pharmaceutical system basically. It’s yeah. It’s like, shouldn’t be, but uh,

 

Kent Holtorf, M.D.

40 years. And then they patented under four conditions.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

There you go. That’s and that’s what they’re aiming at now. And that’s why they got into the game. And that’s why you see things happening slowly. But you know, like with TaylorMade they say, okay, you cannot make this one, this one or this one anymore. And they’re slowly getting to that.

 

Kent Holtorf, M.D.

Don’t worry about compounding pharmacies. And they have the thing with the, we could only where they had a list that you couldn’t compound. Now they’re going to list that this Alicia can compound from, there’s going to be very few things. Like they said things like, Oh, you can’t compound course a 10 because we have a drug for that.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah. So the same argument,

 

Kent Holtorf, M.D.

You know, and, or they’ll say it’s difficult to compound, well difficult for whom.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Right? Let, let, let me leave it to us if it’s difficult or that

 

Kent Holtorf, M.D.

Yeah. And I think com there’s going to be very few things and are, they’ll say, well, someone cakes too much, they could have a problem. You know? And, and with these doctors that were debating, this should be allowed, uh, they would say, well, they wouldn’t even look at the literature. They don’t need to look the literature. Um, yeah, like I’ll fight folic acid. They said, can’t be given IB. Um, and they just eliminating everything. They said they weren’t going to text the hormones, but that’s gonna be on the list. I’m very worried that T3 is going to be gone because they’re going to say, Oh, it’s not necessary. We have Synthroid.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Well, that’s what they did in Canada. You cannot find Teatree anymore. For many years, two, four, that’s it centroid T four. And that’s the only thing there is still like in Montreal, there was one pharmacy compounding pharmacy where I get my, uh, uh, armor, uh, extract. And this is it. And most, uh, Andrew, uh, other chronologist, they, no, they say, no, you ask them, they’re going to say no too far is that.

 

Kent Holtorf, M.D.

Yeah. And you know, I written numerous reviews on how T4 doesn’t work for anyone, especially any sick person. Um, and with hundreds of references, you know, but it feels like, no, no, no, you don’t need it. And I’ll say, it’s dangerous. It’s like, are you kidding me?

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

And, and as a practitioner, you should know. And because I have a doctor, I actually got suspended for nine months because he prescribed the, uh, the, the extract and what he said. Yeah. On paper and studies. Yeah. They do pretty much the same thing. But he said, if you ask the patients are, do you feel, and 80% will tell you, they feel much better with the extract than with the synthetic T four. So yeah, the blood levels, they’re both good.

 

Kent Holtorf, M.D.

It’s like they had bipolar patients that were treatment resistant. They tried on average 14 medication with no improvement. They gave them straight T3, uh, and 80% improved. And, uh, 75% had total resolution of several, I’m sorry, 35% or something like that. Total resolution of symptoms. Yup. T board doesn’t work in these patients there don’t utilize it. But anyways

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

and most, probably some cofactors we don’t even know about yet that support.

 

Kent Holtorf, M.D.

So it sounds like very hopefully upcoming thing. And it doesn’t get quashed by, you know, big pharma and the medical board and FDA are all kind of boots. Um, so yeah. So with, uh, kind of in closing, I think this is really upcoming thing. Where, where do you think it’s kind of an lead?

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Well, I’m just going to say this. Why do you think so many of us and Canadian doctors open clinics in Mexico and the Caribbean? Uh, it’s not because yeah, of course it’s nice, big idea that I would love to have an office there, but that’s not their first reason it’s for that reason basically. So they can continue to offer the best treatments without being bothered by FDA regulations.

 

Kent Holtorf, M.D.

Yeah. And it’s even, I think, you know, in this whole integrative space or whatever you want to call it, you know, the standard doctor was, Oh, there’s no evidence, you know, uh, which is crazy. It’s more evidence-based than what you learn and you know,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

And, uh, it’s, it’s actually a sad thing. That’s happening in medicine in general, you know, 30 years ago when I was young, I would go see because as a doctor, what’s the first thing you do. First thing, when you see a patient, you ask him questions, no tests, no nothing. First questions. And if you’re good, just with that, you know, what’s wrong with him, but now the system, like it doesn’t trust you anymore. They force you to do all those tests to back up your diagnosis that you had probably with 10, 10, 15, depending, but very fast know, after if you have a doctor that has a bit of experience and say, yeah, this is it. This is this. Sometimes they will net a couple of tests. Maybe it’s lupus, maybe it’s fibromyalgia. Let’s look at it, but you have a pretty good idea. Now the system forces you to back up everything you do, why you do it and everything. And I find it amazingly sad because it’s like that all that formation, that knowledge and experience, and suddenly they’re telling you, no, we don’t trust you. Yeah.

 

Kent Holtorf, M.D.

And everything comes down now to terms of the protocols that especially hospital or anyone affiliated with Kaiser or whatever it may be. You do this, do this. Everything is memorization. And it’s, you know, the art of medicine has gone. And I think at some point it’s going to be put all their labs and symptoms in a computer. It’s gonna,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Yeah. AI, that’s where it’s going to.

 

Kent Holtorf, M.D.

And that’s the thing. So all these patients that works well for patients fits in a little box, but if they don’t, that system breaks down and that’s we get the doctor goes, Oh, you must be in your head. You know, that’s a classic, basically they are in the limbo, which I think is where peptides that have a big place. And I think you’d agree with that.

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

If things would go as they should, the future of medicine, and I’m talking five to 10 years, no more, because things are moving fast, you would go see a doctor and probably 60, 70% of this prescriptions would be that diets. And soon not now because with the, um, or, uh, biomes, you know, the, the, the probiotics we have, uh, not, not they’re mapping it, but it’s going to be like the, uh, DNA, you know, you map it. And, you know, 20 years ago said, that’s it though. We, we got it. Then it’d be genetic game. So I think there is a net beach and there’d be biome that goes with that interactions. But once they get down that path, that’s going to be a mainstream. It should be a mainstream in medicine. Right.

 

Kent Holtorf, M.D.

But it’s going to get more complicated because they’re finding the virome, you know, the bacteria, phages, the viruses of the bacteria play a big part. So there it’s very complex

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Tomorrow, but I have big hope cause things are happening faster and faster, another five, 10 years. And they should have a pretty good idea of what to do with that. And that’s going to be a big, big line in medicine to use. I think it’s good.

 

Kent Holtorf, M.D.

Right. So, so just kind of, uh, in closing here, you’d say, um, at battalions, probably the main bio regulator,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

It’s kind of our mono system, you know, that’s regulated the most experience with Andy and Tamerlan. Well, even if you use one that it’s called DEMA land that’s to Mulan. It’s good. It’s that basically, because in those, uh, uh, aging studies and it figures, it Pitano is good. You add [inaudible] or violin, which is, and you can inject it while they’re salute. Uh, if you have a strong immune system, you will get less sick. So hands healthy, more healthy, and yeah, Broley you live longer

 

Kent Holtorf, M.D.

Also, but the immune system goes along with monitoring the body for cancer cancer,

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

The, the main ones and the anti aging protocol, Peter Long, and [inaudible] violent time as an alpha one. You know, one of those will do the trick, uh, that combination it’s a winning company.

 

Kent Holtorf, M.D.

Yeah. I think those are the most studied as well. Yeah. Yeah. And we liked that combination and the other

 

Jean-Francois Tremblay, MD, CM, FRCPC, FAACS

Ones in term of prevention, like the one for the lever and the one for the kidneys for, I would use them in the preventative approach, like a bit alone, if you add a familiar background. So let’s say, you say like half of my family, uh, they got, uh, diabetes. Well, okay. Maybe that’s not so much genetic. It could be you as you pass to your children the way you eat. So it may not be that genetic after all, but anyway, if there is a condition that really then yeah. You could use preventively, the one for the pancreas, if in your family, there is a Whitney weakness for the lungs then. Yeah. Don’t, I, I wouldn’t suggest everybody to use them all, then you’d be taken so many. Yeah. But just to pinpoint one thing or two that you see as kind of a weakness in your family, that’s a good indication. And then you can throw in those and the preventive, uh, protocol. Gotcha.

 

Kent Holtorf, M.D.

Great. Yeah. We’ll see what the future holds and I hope we’ll be talking more about all these and, uh, my pleasure. Yeah. So I thank you so much again, uh, love your personality and, uh, and you’re always searching for new knowledge at this. Wonderful. And so I’d like to thank you for being on with us. Hey, you’re very welcome. My pleasure. Great. Alright, goodbye.

 

 

Join the discussion

or to comment
0 Comments
Inline Feedbacks
View all comments

0
We would love to hear your thoughts. Join the discussion belowx
()
x
drtalks_logo

Single Video Purchase

Combatting the Effects of Stress & Intense Physical Activity: How Peptides Can Help Keep Your Body in Peak Condition

Buy Now - $1.99

Or Access Unlimited Videos from our Library when you subscribe to our Premium membership

Premium Membership

Unlimited Video Access

$19/month    or    $197/year

Go Premium
drtalks logo

SMS number

Login to DrTalks using your phone number

✓ Valid
Didn't receive the SMS code? Resend
drtalks_logo.png

Create an Account

or

Signup with email

Already have an account? Log In

DrTalks comes with great perks that guests to our site don’t have access to. Sign up for FREE

drtalks_logo

Become a member

DrTalks comes with great perks that guests to our site don’t have access to. Sign up for FREE

"*" indicates required fields

Name*
Password*

Already have an account? Log In

drtalks_logo.png

Sign-in

Login to get access to DrTalks wide selection of expert videos, your summit or video purchases.

or